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Abstract
Background: Genetic code expansion has developed into an elegant tool to incorporate unnatural amino acids
(uAA) at predefined sites in the protein backbone in response to an amber codon. However, recombinant
production and yield of uAA comprising proteins are challenged due to the additional translation machinery
required for uAA incorporation.
Results: We developed a microtiter plate-based high-throughput monitoring system (HTMS) to study and optimize
uAA integration in the model protein enhanced green fluorescence protein (eGFP). Two uAA, propargyl-L-lysine
(Plk) and (S)-2-amino-6-((2-azidoethoxy) carbonylamino) hexanoic acid (Alk), were incorporated at the same site into
eGFP co-expressing the native PylRS/tRNAPylCUA pair originating from Methanosarcina barkeri in E. coli. The site-specific
uAA functionalization was confirmed by LC-MS/MS analysis. uAA-eGFP production and biomass growth in parallelized
E. coli cultivations was correlated to (i) uAA concentration and the (ii) time of uAA addition to the expression medium
as well as to induction parameters including the (iii) time and (iv) amount of IPTG supplementation. The online
measurements of the HTMS were consolidated by end point-detection using standard enzyme-linked immunosorbent
procedures.
Conclusion: The developed HTMS is powerful tool for parallelized and rapid screening. In light of uAA integration,
future applications may include parallelized screening of different PylRS/tRNAPylCUA pairs as well as further optimization
of culture conditions.
Keywords: Amber codon suppression, Online monitoring system, High-throughput screening, Unnatural amino acid,
Bio-orthogonal chemistry, Protein engineering
Background
The number of methods for site-specific protein modifi-
cation, allowing precise conjugation of drugs or poly-
mers e.g. for medical imaging or studying of biological
processes with defined fluorescent probes, respectively,
has substantially increased in recent years [1, 2]. Among
them, amber codon suppression (genetic code expan-
sion) has developed into an elegant tool to incorporate
unnatural amino acids (uAA) at predefined sites in the
protein backbone [3–5].
This method is based on the translation machinery
evolved in archaebacteria, which are able to incorporate
the 22nd amino acid L-pyrrolysine (Pyl) as building block
in proteins during translation beyond the typically used
20 canonical amino acids [6, 7]. Pyl is encoded by an
amber termination codon (UAG) within a gene and is
recognized by its orthogonal suppressor tRNAPyl. The
transfer of Pyl to its specific tRNAPyl is catalyzed by a
specific pyrrolysyl-tRNA synthetase (PylRS). Due to high
substrate side chain promiscuity of the PylRS enzyme,
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structural related Pyl analogues with distinct functional
groups can be easily integrated to enable a broad chem-
ical versatility for bioconjugation chemistry [8]. In fact
up to 23 different functional uAA were shown to be in-
corporated using the native PylRS/tRNAPylCUA pair orig-
inated from Methanosarcina barkeri (M. Barkeri) [9].
Moreover, numerous PylRS mutants have been engineered
with improved activities and for recognition of Pyl deriva-
tives, which are not targeted by the native PylRS enzyme.
Whereas other orthogonal synthetase-tRNA pairs derived
from strains like Methanococcus jannaschii are confined to
bacterial cells without further genetic modifications, the
genes of the PylRS-tRNAPylCUA system from Methanosar-
cina species are of broad applicability and have been suc-
cessfully transferred to incorporate uAA in proteins in
more complex hosts such as yeast [10], mammalian
cells [11] or multicellular organisms such as Caenorhab-
ditis elegans [12].
Protein yields, however, are usually lower compared
to the expression levels of the wild-type analogue.
Optimization of uAA incorporation using amber codon
suppression includes (i) variation of uAA addition (concen-
tration and time of addition to the expression medium), (ii)
expression control for the PylRS/tRNAPylCUA pair as well
as for the gene of interest and (iii) quantification of the
desired product. Up to now, reports are based on gel
electrophoresis analysis and, therefore, rather qualitative
or average yields of purified protein are reported [13, 14].
Furthermore, these do not allow online monitoring or
high throughput screening of culture conditions as re-
quired for studies based on experimental design including
the assessment of interactions among parameters (i.e.
questions regarding the impact of one input parameter A
depending on the level of another parameter B).
Consequently, we applied a high-throughput approach
combined with online monitoring of microbial growth
and product formation of a fluorescent reporter protein.
Process parameters with relevance for the insertion of
uAA by the PylRS-tRNAPylCUA system in E. coli were
identified and optimized. The system was further consoli-
dated by end point-detection of the uAA modified fluores-
cent reporter protein in the bacterial supernatant using
standard enzyme-linked immunosorbent procedures.
Results and discussion
Introduction of unnatural amino acids into eGFP by
amber codon suppression
Enhanced green fluorescent protein (eGFP) was used to
monitor uAA incorporation with the pylRS/tRNAPylCUA
pair originated from M. barkeri [14, 15]. The amber
codon (UAG) was integrated into the eGFP sequence at
the N-terminus (residue #4; Lys4/uAA) to exclusively
monitor eGFP formation as result of the successfully in-
tegrated uAA through amber codon suppression (Fig. 1a).
Fig. 1 Introduction of unnatural amino acid into eGFP and high throughput screening. a The amino acid sequence of Lys-eGFP was extended
with two Gly after position 1 and the unnatural amino acid was incorporated at the position of the amber stop codon TAG which was introduced
at position 4 using (b) propargyl-L-lysine (Plk, 1) or (S)-2-amino-6-((2-azidoethoxy)carbonylamino) hexanoic acid (Alk, 2). c Beta barrel structure of
eGFP (PDB ID: 2Y0G) with highlighted chromophore in the center and incorporation site for the unnatural amino acid at the N-terminus at
position 4. d Non-invasive online monitoring of E. coli cultures, producing the unnatural amino acid containing eGFP. The process parameters
unnatural amino acid concentration (cuAA), time of unnatural amino acid addition (tuAA), IPTG concentration (cIPTG) and time of IPTG addition (tIPTG)
were studied in parallelized experiments
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The /tRNAPylCUA was constitutively expressed, whereas
both the pylRS and the UAG-eGFP target gene were
under lac operon control for induction with IPTG [14].
As substrates for the native PylRS/tRNAPylCUA pair two
different well-recognized Pyl derivatives were chosen:
Plk (propargyl-L-lysine; 1) and Alk ((S)-2-amino-6-((2-
azidoethoxy) carbonylamino) hexanoic acid; 2; Fig. 1b).
The azide and alkyne functionalities of the selected uAA
enable biorthogonal click chemistry as demonstrated by
myoglobin [13], ubiquitin [14] or basic fibroblast growth
factor [16] and for site-specific protein modification of the
glycocalyx on living cells [17]. The formation of uAA-
eGFP and biomass is monitored through the transparent
bottom of microtiter plates with a screening platform con-
structed in-house in a modified BioLector setup [18, 19].
An optical fiber connected to a fluorescence spectrometer
was positioned below the microtiter plates and allowed
non-invasive online monitoring without interrupting the
orbital shaking movement required for oxygen supply and
mixing of the culture. The optical fiber automatically
moved so quickly from well to well such that continuous
monitoring of up to 4 microtiter plates was achieved pro-
viding on the fly comparison of various process parameters
through quasi-simultaneous read-outs (Fig. 1d).
Initially, we confirmed the successful incorporation of
uAA into eGFP by amber codon suppression for two
uAAs Plk-eGFP and Alk-eGFP (Fig. 1b; in parallel to ex-
pression of the control Lys-eGFP; Fig. 1c) using 3 mM
uAA in TB-medium following standard expression proce-
dures [15, 16]. Expression of Plk-eGFP and Alk-eGFP
compared to Lys-eGFP (positive control) and to IPTG in-
duced bacteria transformed with the pylRS/tRNAPylCUA
pair but without the addition of the uAA (negative con-
trol) was analyzed in total cell lysates after 6 h of expres-
sion by SDS-PAGE (Fig. 2A,a) followed by Western
blotting to confirm the protein’s identity (Fig. 2A,b). As
expected expression of wild-type Lys-eGFP was highest as
demonstrated by SDS-PAGE and Western blotting and in
comparison to Plk-eGFP and Alk-eGFP, respectively. As
next we isolated all eGFP constructs from cell lysates by
metal ion affinity chromatography. Purification of all eGFP
analogues resulted in high purity as determined by SDS-
PAGE analysis (Fig. 2A,c). eGFP fluorescence is linked to
proper eGFP folding into the characteristic GFP β-barrel
structure (Fig. 1c). To investigate the effects of uAA inser-
tion, which may interfere with the tertiary structure of
eGFP, affecting its fluorescence properties, purified Plk-
eGFP and Alk-eGFP were analyzed by fluorescence spec-
troscopy in comparison to the control protein (Fig. 2B).
Both eGFP analogues showed identical fluorescence signa-
tures with λmax = 510 nm of eGFP as previously described
[20], indicating that uAA insertion did not interfere with
eGFP β-barrel maturation. MALDI-MS analysis suggested
N-terminal Met removal from all eGFP constructs upon
translation through E. coli derived methionine amino pep-
tidase (MetAP) (Additional file 1: Figure S1). This finding
was corroborated by elastase digests of Plk-eGFP and
Alk-eGFP followed by LC-MS/MS analysis confirming
the insertion of Plk (Fig. 2C) and Alk (Fig. 2D) at pos-
ition #4 in the amino acid sequence. This characterized
eGFP fluorescence reporter system marked the starting
point for deploying the screening platform.
Online measurement of biomass and Plk-eGFP formation
During initial cultivations an increase in raw eGFP fluores-
cence intensity (475/507 nm) was not exclusively detected
for induced cultures expressing Plk-eGFP but also for
non-induced cultures with about 40 % final fluorescence
intensity compared to induced cultures (Fig. 3a). ELISA
measurements confirmed the formation of Plk-eGFP in in-
duced cultures but the absence of eGFP in non-induced
cultures (data not shown). We hypothesized that a super-
imposition of biogenic flavin fluorescence was the cause
for the detected signal increase in non-induced cultures.
In contrast to commercially available BioLector setups
that rely on fixed combinations of excitation and emission
filters for detection of fluorescence signals the monochro-
mators of the in-house constructed HTMS enable mea-
surements at all wavelength combinations in the UV-Vis
range. With this system in our hands, we selectively moni-
tored in parallel an additional flavin fluorescence intensity
signal over the course of the cultivation (450/528 nm,
Fig. 3b, left axis, squares). For non-induced cultures (grey),
this signal correlated well to the scattered light intensity
indicating biomass formation (650/650 nm, right axis, cir-
cles). Induced cultures (red) showed an over proportional
increase driven by the overlapping fluorescence of the
formed Plk-eGFP. By applying routinely used unmixing
methods the eGFP fluorescence signal could be corrected
by subtracting the flavin signal multiplied by the ratio of
raw eGFP to flavin fluorescence intensity at the end of non-
induced cultivations after 36 h (IeGFP,corrected = IeGFP,raw –
0.47 Iflavin) [21, 22]. As expected the corrected eGFP signal
showed a strong increase during cultivation of induced cul-
tures and alternated around zero for non-induced cultures
(Fig. 3c). All following eGFP signals were corrected for
autofluorescence applying this method.
Four process parameters were screened in parallel for
relevance to uAA incorporation: (i) the uAA concentra-
tion (cuAA) and (ii) time of supplementation (tuAA) as
well as (iii) the inducer concentration (cIPTG) and (iv)
the time of induction (tIPTG) (Fig. 1d). These parameters
were systematically varied in parallelized cultivations and
biomasses as well as Plk-eGFP formation were monitored
online. The online monitoring experiments indicated a
minor impact of the Plk concentration on biomass forma-
tion (Fig. 4a). Up until the end of the exponential growth
phase after 12 h the scattered light signals quantitatively
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reflecting biomass concentrations were very similar for
0–70 mM Plk. After 12 h cultures with high Plk con-
centrations (50 mM, 70 mM) showed lower growth
rates resulting in 14–24 % lower biomass at the end of the
experiment. In contrast, Plk-eGFP formation strongly
depended on Plk concentration (Fig. 4b) peaking at the
end of the growth phase after approx. 15 h. Increasing the
Plk concentration from 0–30 mM strongly increased
Plk-eGFP formation, while further supplementation up
to 50 mM Plk did not impact outcome. The observed
Fig. 2 a Analysis of eGFP expression. a SDS-PAGE and b Western Blot and Ponceau S staining as loading control of total cell extracts. The positive
control (Lys-eGFP) was diluted 1/10 for Western blot analysis to prevent overexposure. c SDS-PAGE of purified Plk-eGFP and Alk-eGFP in comparision to
wild-typ Lys-eGFP. b normalized fluorescence spectra of Lys-eGFP, Plk-eGFP and Alk-eGFP. ESI-MS/MS spectra of elastase digested Plk-eGFP (c) and
Alk-eGFP (d), respectively, with assigenment of the fragments to the uAA-eGFP amino acid sequence
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drop in Plk-eGFP formation at 70 mM possibly reflected
growth limitations as indicated in the biomass signal
(Fig. 4a).
The time of Plk supplementation did not impact bio-
mass formation (Fig. 4c). In contrast, eGFP fluorescence
was detected within 30 min after Plk supplementation
(Fig. 4d). Especially late Plk supplementations after 10 or
12 h of cultivation – when more biomass was present
for eGFP formation – sparked a steep increase in eGFP
fluorescence. The fast fluorescence response measured
with the online monitoring system provided evidence
that the PylRS catalyzed transfer of Plk to the tRNA was
not rate limiting under the selected culture conditions
and sufficient expression level of PylRS were achieved.
Later Plk supplementation decreased eGFP fluorescence
signals as compared to earlier time-points demonstrating
the positive impact of early Plk supplementation on Plk-
eGFP formation.
Induction with IPTG decelerated growth (Fig. 4e).
Supplementation with 150–500 μM IPTG retarded the
end of the exponential phase by 1.5 h as compared to
non-induced cultures and decreased final scattered light
intensity by about 20 % (Fig. 4e). These reductions in
biomass following IPTG reflect the metabolic burden in-
troduced by the heterologous protein production [23].
The amount of formed eGFP was not impacted by cIPTG
as tested within a range of 150–500 μM (Fig. 4f ). tIPTG
scarcely impacted biomass formation (Fig. 4g). Early in-
duction after 4 or 6 h slightly reduced growth rates
reflecting the shift of cellular resources from biomass
formation into eGFP formation (Fig. 4g). Consequently,
earlier tIPTG resulted in higher eGFP formation (Fig. 4h).
Online fluorescence monitoring also showed a delay of
at least 1 h between IPTG supplementation and eGFP
detection (Fig. 4h). This is in contrast to shorter re-
sponse time of about 30 min following Plk addition
(Fig. 4d). This difference at least partly reflects the add-
itional time requirement for the assembly of PylRS and
tRNAPlkCUA as a prerequisite for Plk-eGFP expression.
Optimization of uAA incorporation and induction
parameters
We now shifted the experimental design (one parameter
was varied while the other three were constant) to a
two-stage screening in full-factorial design mode for
rigorous parameter optimization. The first stage was
used to identify the most significant parameters and to
shift and narrow the design space around the optimum
(Additional file 1: Table S1). In the second stage a re-
sponse surface model including quadratic interactions
was constructed as linear combination of significant terms
(main: cPlk, cIPTG, tIPTG; linear interaction: cIPTG
.tIPTG;
quadratic interaction: tIPTG
2, Additional file 1: Figure
S2). The model predicted the Plk-eGFP fluorescence in-
tensity (IPlk-eGFP, [a.u.]) as a function of Plk concentra-
tion (cPlk, [mM]), IPTG concentration (cIPTG, [μM])
and the time of IPTG addition (tIPTG, [h]) following
IPlk ‐ eGFP = 2489 ⋅ cPlk ‐ 27.02 ⋅ cIPTG ‐ 27561 ⋅ tIPTG ‐ 9456 ⋅
tIPTG
2 + 42.02 ⋅ cIPTG ⋅ tIPTG + 696949, adequately de-
scribing the system (Additional file 1: Figure S3). This
Fig. 3 Correction for flavin autofluorescence. a Raw eGFP
fluorescence intensity (λEx = 475 nm, λEm = 507 nm) of non-induced
cultures (grey) and induced cultures supplemented with 433 μM
IPTG and 38 mM Plk (red). b Flavin fluorescence intensity (left axis,
squares, λEx = 450 nm, λEm = 528 nm) and scattered light intensity
(right axis, circles, λEx = 650 nm, λEm = 650 nm). Only every 5th data
point is shown to improve readability. c Corrected eGFP signal
(IeGFP,corrected = IeGFP,raw – 0.47 Iflavin) as applied in subsequent figures.
Error bars indicate standard deviation of triplicates
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result was confirmed by an independent validation
run (Additional file 1: Figure S4) and was graphically
represented (Fig. 5). As indicated by dark red colors,
highest eGFP formation followed 300–400 μM IPTG
when added at the beginning of the experiment (0–0.5 h
of cultivation) and when high Plk concentrations (38 mM)
were added right at the start of the cultivation. The
commonly applied method of IPTG induction in the
early exponential growth phase (after approx. 9 h) was,
therefore, inappropriate to yield the optimum of Plk-
eGFP formation within the specific pattern described
herein [24].
IPTG concentrations of 400–1000 μM IPTG yielded
comparable outcome reflecting saturated protein forma-
tion capacities and opening the possibility of reducing
IPTG while maintaining maximum Plk-eGFP formation
Fig. 4 Online measurement of biomass and Plk-eGFP formation. Scattered light intensity as a measure for biomass (first column) and eGFP
fluorescence intensity (second column) over time of culture of E. coli BL21(DE3) uAA-eGFP cultures. Four process parameters were varied
individually: (a, b) Plk concentration cplk = 0–70 mM; (c, d) time of Plk addition tplk = 4–2 h (e, f) IPTG concentration cIPTG = 0–500 μM (g, h) and time of
IPTG addition tIPTG = 4 – 12 h. If not varied, parameters were fixed at cPlk = 10 mM, tPlk = 4 h, cIPTG = 200 μM and tIPTG = 4 h respectively. No Plk and no
IPTG was added to cultures designated as ‘non-induced’ (dark grey). Small down-pointing arrows indicate the time of Plk and IPTG supplementation
and large vertical arrows indicate trends in eGFP fluorescence after 32 h
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(Additional file 1: Figure S5). The set point aiming for a
robust process outcome (i.e. deviation of input parameters
from the set point would not significantly impact the Plk-
eGFP concentration) were calculated via Monte-Carlo
simulation at cPlk = 38 mM, tPlk = 0 h, cIPTG = 433 μM,
tIPTG = 0.2 h (Additional file 1: Figure S6) and characterized
by measuring Plk-eGFP concentrations using ELISA. Cor-
roborating the online fluorescence measurements (Fig. 3),
Plk-eGFP concentrations strongly depended on the Plk
concentration (Fig. 6a). With 38 mM Plk and 433 μM IPTG
added at the beginning of the cultivation a Plk-eGFP
concentration of 3.17 ± 0.06 μg mL-1 was achieved
while with a generally used concentration of 3 mM Plk
only 0.45 ± 0.07 μg mL-1 were produced under otherwise
identical experimental conditions. eGFP concentrations
(determined by ELISA) and eGFP fluorescence intensities
detailed by the HTMS correlated linearly (Fig. 6b).
Side chain promiscuity of the PylRS enzyme allows the
incorporation of different uAAs than Plk into eGFP
using the same setup. Instead of Plk’s terminal alkyne
functionality we now changed to an azide functionality
Alk ((S)-2-amino-6-((2-azidoethoxy) carbonylamino) hexa-
noic acid) (Fig. 1b). Both, terminal azide and alkyne func-
tionalities profile proteins for copper(I)-catalyzed azide
alkyne cycloaddition (CuAAC) [25, 26]. Straightforward ex-
trapolating of the optimized set point found for Plk-eGFP
formation to Alk-eGFP resulted in immediately achieved
concentrations of 2.56 ± 0.13 μg mL-1 (Fig. 6a, black bar;
Fig. 6b, Alk-38). The amount of supplied Alk critically
drove uAA-eGFP formation as read from online monitored
fluorescence (Fig. 6c). Starting off these results, rapid
process optimization for Alk by using 10 mM Alk instead
of 30 mM Plk readily boosted maximum eGFP fluorescence
intensities beyond the results obtained for Plk-eGFP, pos-
sibly reflecting a higher PylRS affinity for Alk in comparison
to Plk. Nevertheless, both concentrations found for the op-
tima (10 mM for Alk and 30 mM for Plk) were far beyond
commonly applied uAA concentration, typically in the
range of 1 mM [27–30], although higher uAA concentra-
tions have already been linked to increased target protein
concentration as estimated after expression and purification
[31–33]. However, high uAA concentrations – as demon-
strated for Alk and Plk here – are not cost-effective for
large scale expression and are therefore still the limiting
factor in genetic code expansion technology.
The HTMS allows for rapid screening and the examples
provided above demonstrated the power of parallelized as-
sessments, yielding rapid optimization of culture condi-
tions while readily balancing the need for high titers and
robust processes for reproducible batch-to-batch outcome.
Optima identified for Plk-eGFP and Alk-eGFP concen-
trations approximated titers of wild-type, unmodified
Lys-eGFP (4.98 ± 0.23 μg mL-1 produced under the same
conditions (Fig. 6b, Lys) performing at 36 % and 49 % rela-
tive to the wild-type, respectively. Recent progress in the
field of genetic code expansion can conveniently be
screened and optimized by this setup. This includes the
selection of improved uAA tRNA synthetases [28, 31, 34],
the use of special ribosomes for uAA incorporation and
systems addressing the competition of the uAA-tRNA
with release factor 1 (RF1) at the amber stop codon
[35–37]. The system can also serve by providing a more
holistic landscape rather than point measurements for
mechanistic studies in analogy to investigations into
the role of tRNA delivery to the ribosome [38, 39].
Obviously, each protein requires the identification of a
new design space and uAA-eGFP was herein used to
demonstrate the proof of concept. For uAA-GFP, a very
early induction optimum (tIPTG = 0.2 h) was determined
with the two-stage screening. Induction after just 3 h of
cultivation already impaired target protein production by
15 % (Fig. 5). Furthermore, no deviations in growth rates
were detected upon addition of up to 40 mM of Plk
(Fig. 4a). This shows that unintended uAA incorporation
into host protein that could reduce fitness and product
formation capabilities is of no concern here. If that was
the case, the optimal induction time would lie after the
early exponential growth phase when further cell growth
has a lesser effect on final product concentration. The
early induction optimum also reflects the general need
Fig. 5 Response surface model for Plk-eGFP production. eGFP fluorescence of E. coli BL21(DE3) uAA-eGFP cultures after 24 h as predicted by the
response surface model as a function of Plk concentration, IPTG concentration and time of IPTG addition (tplk = 0 h). Dark red colors indicate
operating conditions which lead to high Plk-eGFP fluorescence
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for early induction times when working within the specific
context of uAA incorporation, caused by the additional re-
quirement of tRNAuAACUA pair formation as compared to
wild type expression. Previous studies already demon-
strated the advantages of independently controlling the
incorporation machinery versus the target gene, thereby
fine-tuning protein ratios for uAA incorporation [32].
Moreover, the influence of the location of the amber
codon within the gene – ranging from initial to terminal
integration of the uAA at the ribosome – on eGFP expres-
sion levels can be detailed by the HTMS presented here.
High-throughput experimentation with concise
optimization steps is highly beneficial to quickly adjust
parameters for each target protein. Current studies
starting off what is described here aim at expanding
the application to non-fluorescent proteins. While the
overall approach remains identical, these systems need
to shift from monitoring of fluorescent proteins (Fig. 1d)
to other available online signals like biomass and oxygen
transfer rate. Preliminary experiments already indicated
that a measurement of the metabolic burden induced
by heterologous protein formation can be used to as-
sess non-fluorescent protein formation during genetic
code expansion.
Conclusions
We provide a high throughput assessment platform de-
signed for parallel screening and optimization studies.
The platform allows massive data generation leading to
optimized design spaces for input parameters, including
but not limited to the use of novel uAA, advanced expres-
sion systems, future synthetases, location of the amber
codon and multiple uAA integration sites or allows in-





acid (Alk) was purchased from IRIS Biotech GmbH
(Marktredwitz, Germany) or was kindly provided by EMC
Microcollections GmbH (Tübingen, Germany). Restriction
endonucleases were from New England Biolabs (Ipswitch,
Fig. 6 a Concentration of uAA-eGFP after 24 h in culture as a function
of uAA concentration. Each column represents the mean + SD of four
independent experiments (p < 0.001). b Comparison between protein
concentrations of eGFP analogues as determined by ELISA and online
measured fluorescence intensities of eGFP analogues. Data points
illustrated as squares and labeled with Plk represent Plk-eGFP samples,
whereas diamonds and circles display Alk-eGFP and Lys-eGFP,
respectively. Tags indicate the uAA concentration in mM. All results
are given as mean ± SD (n = 4) (c). Online measured fluorescence
intensities of eGFP analogues in respect to uAA concentration.
uAA and IPTG (433 μM) were added at the start of the cultivation
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MA). Pfu DNA polymerase was from Stratagene (La Jolla,
CA). Boc-protected L-lysine was from P3 BioSystems LLC
(Shelbyville, KY). Coomassie Brilliant Blue G250 and Brad-
ford Protein Assay Kit were from Pierce (Rockford, USA).
GFP ELISA Kit Simple step (#ab171581) was from Abcam
(Cambridge, United Kingdom). Acetonitrile (HPLC grade)
and trifluoroacetic acid (HPLC grade) were from VWR
(Ismaning, Germany). Anti-GFP Antibody #2555 and Anti-
rabbit IGG HRP-linked Antibody # 7074 were purchased
from Cell Signaling (Hitchin, United Kingdom). Super
Signal West Pico Luminescent Substrate was purchased
from Thermo Scientific (Waltham, MA). All other che-
micals used were at least of pharmaceutical grade and
were purchased from Sigma-Aldrich (unless noted other-
wise). Propargyl-L-lysine (Plk) was prepared as HCl-salt as
previously described [16].
Subcloning, expression and purification of eGFP
analogues (Lys-eGFP, Plk-eGFP and Alk-eGFP)
The pEGFP-N1 plasmid containing the gene encoding for
full length enhanced green fluorescent protein (eGFP) were
from Clontech Laboratories, Inc. (Mountain View, CA).
For the Lys-eGFP mutant, the initial cDNA was amplified
by PCR using a forward primer including an NdeI restric-
tion site and two additional glycine codons inserted after
the methionine start codon (5‘-CCCCATATGGGCGG
TGTGAGCAAGGGCGAGGAGCTG-3’), while deploying
a reverse primer including a 6 × histidine tag and an EcoRI
restriction site (5‘CCCGGATCCTTAGTGGTGATGGTGA
TGATGCTTGTACAGCTCGTCCATGCCG-3’). In order
to obtain 4(TAG)-eGFP, the forward primer was altered to
5‘CCCCATATGGGCGGTGTGAGCTAGGGCGAGGAG
CTG-3’ substituting AAG (Lys) with amber codon TAG.
After digestion with NdeI and EcoRI, the resulting cDNAs
Lys-eGFP and 4(TAG)-eGFP were subcloned into the
backbone of a pET11a vector-construct, containing the
gene for the pyrrolysine tRNA, the lipoprotein promotor
lpp, the terminator RRN b/c and an ampicillin resist-
ance gene as described in Eger et al. [14] By means of
T7-term promoter based DNA sequencing the correct
sequence of both inserts was confirmed. Subsequently,
the pET11a plasmids were co-transformed with a
pRSF-duet vector, providing the gene for the pyrroly-
sine tRNA synthetase and kanamycin resistance, into
the E. coli BL21(DE3) for amber codon suppression as
previously described [25].
For SDS-page, fluorescence spectra and MALDI-MS,
bacteria were cultured in 2 L baffled flasks inoculated
with 1 % overnight culture at 37 °C and 130 rpm in
500 mL Terrific Broth (TB) medium supplemented with
100 μg mL-1 carbenicillin, 34 μg mL-1 kanamycin, 2 mM
MgSO4 and 50 μL of polypropylene glycol as an anti-foam
agent in an environmental Shaker 10× 400 (SANYO
Gallenkamp, Leicestershire, UK) with a shaking diameter
of 32 mm [15, 16]. Plk or Alk were added to a final con-
centration of 3 mM at an OD600 = 0.4. eGFP expression
was induced with 1000 μM IPTG at OD600 = 0.6-0.7 and
the bacteria were cultivated at 33 °C and 130 rpm. After
6 h, the bacteria were harvested by centrifugation and the
pellets were washed and resuspended in lysis buffer
(20 mM phosphates, 500 mM NaCl and 25 mM imidazole,
pH 7.5). Cells were solubilized by cell disruption with a
SONOPULS Ultrasonic homogenizer HD 3100 system
(Bandelin, Berlin, Germany) at 4 °C, in lysis buffer con-
taining 1 mM PMSF. After centrifugation at 100.000 g for
1 h at 4 °C (L8-60 M Ultracentrifuge, Beckman-Coulter,
Brea, CA), the supernatant with His-tagged eGFP mutant
was purified by immobilized metal ion affinity chroma-
tography deploying an FPLC system (Aekta Purifier,
GE, Freiburg, Germany) with a HisTrap FF (Ni Sepharose)
crude 1 mL column (GE, Freiburg, Germany). Elution was
initiated using a linear gradient of imidazole ranging from
25 mM to 500 mM. Combined fractions were dialyzed
against PBS and the concentrations were determined by
Bradford protein assay following the manufacturer’s in-
structions. Lys-eGFP was isolated in average yields of
15 μg mL-1 expression culture and the average yield of
Plk-eGFP and Alk-eGFP was approximately 2 μg mL-1 ex-
pression culture, respectively.
Cell lysate analysis and western blotting
1 mL bacterial suspension of each expression was centri-
fuged and gently washed in PBS. Obtained pellets were
resuspended in SDS-loading buffer, lysed at 95 °C and
centrifuged again. Sample supernatants were then ana-
lyzed by SDS-PAGE followed by Western blotting. The
supernatant of the positive control (Lys-eGFP) was di-
luted 1:10 for Western blot analysis. As loading control,
the blotted nitrocellulose membrane was stained with
Ponceau S (0.2 % solution in water) prior before incuba-
tion with an anti-GFP antibody (1:1000 in Tris-buffered
saline, containing 0.1 % (w/w) Tween 20). After incuba-
tion with a peroxidase conjugated secondary antibody
(1:1000 in Tris-buffered saline, containing 0.1 % (w/w)
Tween 20), the signal intensity was assessed using a
Super Signal West Pico Luminescent Substrate and a
FluorChem FC2 imaging system from Protein Simple
(Santa Clara, CA).
SDS-PAGE
Expressed proteins were analyzed by standard tris-
glycine SDS-polyacrylamide gel electrophoresis. Gels
were stained with Coomassie Brilliant Blue G250 and
photographed using a FluorChem FC2 imaging system
(ProteinSimple, San Jose, CA).
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Fluorescence spectroscopy
Fluorescence spectra were obtained on a LS 50B Fluor-
escence Spectrometer (PerkinElmer, Waltham, MA). All
spectra scans were recorded from 200–800 nm with a
scan speed of 150 nm min-1, applying a solution of each
eGFP analogue with a concentration of 30 μg mL-1 in a
quartz cuvette as measuring cell. Emission spectra were
excited at 488 nm and excitation spectra where moni-
tored at 510 nm following the predefined values re-
ported in [20]. The slit width was set to 4.7 nm for
emission and 9.7 nm for excitation.
MALDI-MS
A solution of 20 μg in 50 μL of protein sample was acid-
ified with 0.1 % TFA and desalted using Zip Tip® pipette
tips (C18 resin, Millipore, Billerica, USA) according to
the manufacturer’s instructions. One μL of the eluate
was embedded in a matrix, consisting of equal parts of
4-Bromo-α-cyanocinnamic acid and ACN/0.1 % TFA in
water (1:4). Matrix-assisted laser desorption ionization
(MALDI)-MS spectra were acquired in linear positive
mode with a 337 nm wavelength nitrogen laser (Autoflex
II LRF, Bruker Daltonics Inc., Billerica, USA). Mass spec-
tra were calibrated externally with protein standard I
(Bruker Daltonics Inc., Billerica, USA) containing insu-
lin, ubiquitin, myoglobin and cytochrome C. Theoretical
masses of wild-type proteins were calculated (http://
web.expasy.org/peptide_mass) and adjusted for theoret-
ical masses of non-canonical amino acids if necessary.
NanoLC MS/MS
For in-gel digestion excised gel bands were destained
with 30 % ACN, shrunk with 100 % ACN, and dried in a
Vacuum Concentrator (Concentrator 5301, Eppendorf,
Hamburg, Germany). Digests with elastase was per-
formed overnight at 37 °C in 0.1 M NH4HCO3 (pH 8).
About 0.1 μg of protease was used for one gel band. Pep-
tides were extracted from the gel slices with 5 % formic
acid. NanoLC-MS/MS analyses were performed on an
LTQ-Orbitrap Velos Pro (Thermo Scientific) equipped
with an EASY-Spray Ion Source and coupled to an EASY-
nLC 1000 (Thermo Scientific). Peptides were loaded on a
trapping column (2 cm × 75 μm ID. PepMap C18 3 μm
particles, 100 Å pore size) and separated on an EASY-
Spray column (25 cm × 75 μm ID, PepMap C18 2 μm
particles, 100 Å pore size) with a 30 min linear gradient
from 3–30 % ACN and 0.1 % formic acid. MS scans
were acquired in the Orbitrap analyzer with a reso-
lution of 30,000 at m z-1 400 for MS scans and 7,500
at m z-1 400 for MS/MS scans using HCD fragmenta-
tion with 30 % normalized collision energy. A TOP5
data-dependent MS/MS method was used; dynamic
exclusion was applied with a repeat count of 1 and
exclusion duration of 30 s; singly charged precursors
were excluded from selection. Minimum signal threshold
for precursor selection was set to 50,000. Predictive AGC
was used with a target value of 1e6 for MS scans and 5e4
for MS/MS scans. Lock mass option was applied for in-
ternal calibration in all runs using background ions
from protonated decamethylcyclopentasiloxane (m z-1
371.10124).
Cultivation conditions
A two stage precultivation was performed in 250 mL
shake flask on orbital shakers (LS-X, Kuhner, Switzerland)
with a filling volume of 10 mL, a shaking frequency of
350 rpm, a shaking diameter of 50 mm and an initial
OD600 of 0.1 for all cultivation stages [23]. The first pre-
cultivation stage was inoculated from cryogenically pre-
served cultures and conducted at 37 °C in Terrific Broth
(TB) medium (5 g L-1 glycerol, 24 g L-1 yeast extract,
12 g L-1 tryptone, 12.54 g L-1 K2HPO4, 2.3 g L
-1 KH2PO4;
all medium components from Roth, Germany) [40]. After
4 h of cultivation, the first precultivation stage was used to
inoculate the second precultivation stage which was per-
formed at 30 °C in modified Wilms-MOPS minimal
(WM) medium (20 g L-1 glucose, 6.98 g L-1 (NH4)2SO4,
3 g L-1 K2HPO4, 2 g L
-1 Na2SO4, 41.85 g L
-1 (N-morpho-
lino)-propanesulfonic acid (MOPS), 0.5 g L-1 MgSO4 ·
7H2O, 0.01 g L
-1 thiamine hydrochloride, 1 mL L-1 trace
element solution [0.54 g L-1 ZnSO4 · 7H2O, 0.48 g L
-1
CuSO4 · 5H2O, 0.3 g L
-1 MnSO4 · H2O, 0.54 g L
-1 CoCl2 ·
6H2O, 41.76 g L
-1 FeCl3 · 6H2O, 1.98 g L
-1 CaCl2 · 2H2O,
33.4 g L-1 Na2EDTA (Titriplex III)], pH adjusted to 7.5
with NaOH) [41]. After 7 h of cultivation, this second pre-
culture stage was used to inoculate the main culture in
48-well FlowerPlates (MTP-48-B, lot 15xx, m2p-labs,
Germany) which was performed at 30 °C with WM
medium. A filling volume of 780 μL per well, a shaking
frequency of 1000 rpm and a shaking diameter of 3 mm
were used. The plates were sealed with a sterile self-
adhesive polyolefin sealing foil (900371, HJ-Bioanalytik,
Germany) to reduce evaporation while still allowing suffi-
cient gas transfer. During cultivation, final concentrations
of IPTG (0–1000 μM) and uAA (0–80 mM) were adjusted
by adding 20–70 μL of concentrated stock solutions after
shortly reducing the shaking frequency to 100 rpm. All
media were supplemented with 100 μg mL-1 carbenicillin
and 34 μg mL-1 kanamycin.
Online monitoring of uAA-eGFP formation and biomass
growth (BioLector)
Scattered light and fluorescence measurements were per-
formed through the transparent bottom of the microtiter
plates with an in-house constructed screening system
based on the established BioLector setup [18, 19, 42]. In
short, a quartz/quartz multi-mode fiber (LUV 105 μm,
LEONI, Germany) was moved sequentially below the wells
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of up to four microtiter plates by a Cartesian motion system
(CMS, Bosch Rexroth, Germany). The fiber was connected
to a spectrofluorometer with excitation/emission mono-
chromators (Fluoromax-4, HORIBA Jobin Yvon GmbH,
Germany) and allowed quasi-continuous and contactless
measurements on up to 4 microtiter plates in parallel with-
out stopping the shaking movement which otherwise might
have resulted in cell sedimentation and oxygen limitation.
For each well eGFP fluorescence intensity (IeGFP,raw)
was measured for 600 ms at an excitation wavelength of
475 nm, an emission wavelength of 507 nm and a band-
pass of 6 nm. Flavin fluorescence intensity (Iflavin) were
measured for 600 ms at an excitation wavelength of
450 nm, an emission wavelength of 528 nm and a band-
pass of 6 nm to correct the eGFP signal for biogenic au-
tofluorescence (IeGFP,corrected = IeGFP,raw – 0.47 Iflavin).
Backscatter intensity as a signal for biomass was moni-
tored for 900 ms at 650 nm with a bandpass of 4 nm.
Correlations between backscatter intensity, optical dens-
ity and cell dry weight can be established as described
previously [19, 43]. For raw eGFP and flavin fluorescence
measurements the mean relative standard deviations of
two sets of triplicates (non-induced, induced) over a culti-
vation time of 36 h (326 data points) were 1.15 ± 0.63 %
and 0.95 ± 0.72 % respectively (Fig. 3). Relative standard
deviation of corrected end-point eGFP fluorescence as ap-
plied in the screening stage was 2.9 % (n = 4).
Response surface model
The formation of Plk-eGFP was analyzed as a function
of four process parameters: (i) Plk conc., (ii) Plk time of
addition, (iii) IPTG conc. and (iv) IPTG time of addition.
The results of the first screening stage which considered
the four process parameters (main effects) and linear in-
teractions (Additional file 1: Table S1) were used to esti-
mate the design space for the second stage which
additionally considered quadratic interactions in central
composite face-centered design (Additional file 1: Figure
S2). The model coefficients were scaled and centered to
allow a comparison of effects and their significance was
determined (Additional file 1: Figure S3). The significant
terms were used to construct a response surface model
that predicts Plk-eGFP fluorescence as a function of Plk
conc., IPTG conc. and IPTG time of addition. A validation
run with 12 conditions plus center point was performed
and showed that predicted and measured fluorescence in-
tensities were in good agreement (Additional file 1: Figure
S4). A robust setpoint for Plk-eGFP formation was de-
termined by Monte-Carlo simulation (50,000 predicted
fluorescence intensities, minimum threshold: 710,000 a.u.,
median: 739,511 a.u., Additional file 1: Figure S6). Experi-
ments were conducted in duplicates (triplicate for center
points). Design of experiments and data analysis were per-
formed with MATLAB (R2012b, The MathWorks, USA)
and MODDE Pro (v11.0.0.1717, MKS Umetrics AB,
Umeå, Sweden) and in accordance with the manufac-
turer’s instructions. The amount of Plk-eGFP produced at
the optimized set points was subsequently determined by
ELISA.
eGFP quantification by Enzyme Linked Immunosorbent
Assay (ELISA)
Precultivations for ELISA measurements were performed
as described for the online monitoring experiments. The
main cultivation was conducted in shake flasks instead of
microtiter plates to generate sufficient biomass for sub-
sequent analysis. Cultivation conditions were the same
as in the second precultivation step described above
(VL = 10 mL, n = 350 rpm, d0 = 350 rpm, T = 30 °C).
The production of uAA-eGFP was induced with a final
IPTG concentration of 433 μM and 0–38 mM uAA at
the start of the cultivation. After 24 h of cultivation,
eGFP fluorescence was measured in 48-well Flower-
Plates as described for the online monitoring experiments.
Additionally, bacterial pellets from 8 mL expression cul-
tures were washed in PBS and resuspended in 1 mL ex-
traction buffer supplemented with extraction enhancer
solution provided by the eGFP ELISA Kit resulting in a
total volume of approximately 1.2 mL bacterial suspen-
sion. 1 mL of this suspension was transferred into a 2 mL
tube and 10 μL of a 0.1 M PMSF solution as well as 0.5 μL
poly(propylene) glycol were added. Cell lysis was per-
formed with a SONOPULS Ultrasonic homogenizer HD
3100 system in six sonication cycles (Bandelin, Berlin,
Germany). Each cycle lasted for 30 s applying 0.6 s pulses
in 1.2 s intervals with an amplitude of 80 % followed by a
pause of 45 s. After this procedure samples were centri-
fuged at 12.000 g for 20 min at 4 °C and aliquots of the
supernatants were used for eGFP quantification. ELISA
was performed following the manufacturer’s instructions.
Absorbance of the acidified 3,3’,5,5’-tetramethylbenzidine
diimine product was determined at 450 nm using a
Spectramax 250 microplate reader (Molecular Devices,
Sunnyvale, CA). All preparation steps were conducted on
ice and with precooled solutions. Data were analyzed by a
Welch’s t-test using Minitab 17 (Minitab, Coventry, UK).
Presented data are depicted as mean + SD; results were
considered statistically significant at p ≤ 0.001.
Additional file
Additional file 1: Supplemental Figures S1–S7, Table S1 and further
information are given in the SI. (PDF 455 kb)
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